GABRIEL HABIB to Treatment Outcome
This is a "connection" page, showing publications GABRIEL HABIB has written about Treatment Outcome.
Connection Strength
0.071
-
Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper. J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):516-25.
Score: 0.038
-
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT. J Am Soc Hypertens. 2014 Nov; 8(11):808-19.
Score: 0.010
-
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
Score: 0.007
-
Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Am J Cardiol. 2008 Nov 15; 102(10):1356-60.
Score: 0.006
-
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005 Apr 06; 293(13):1595-608.
Score: 0.005
-
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25.
Score: 0.005